Emerging Therapies for Androgenetic Alopecia.
Androgenetic alopecia is the progressive miniaturization of the scalp's terminal follicles in aging men. Over 40% of Caucasian men develop hair loss by the age of 40. Despite its prevalence, there are only two FDA approved medications to treat the condition. Recognizing the unmet need, new medical, procedural, and surgical treatments are being adopted to combat progressive hair loss. This review examines emerging hair loss treatments including medical therapies that the target prostaglandins, low level light therapy, platelet rich plasma injections, and robotic hair transplantation.
Terrence
T
Keaney
D000505:Alopecia / Q000378:metabolism / Q000628:therapy*; D015237:Dinoprost / Q000031:analogs & derivatives; D018859:Hair Follicle / Q000637:transplantation*; D006801:Humans; D028022:Low-Level Light Therapy; D008297:Male; D053657:Platelet-Rich Plasma; D015230:Prostaglandin D2 / Q000037:antagonists & inhibitors; D011453:Prostaglandins / Q000378:metabolism; D065287:Robotic Surgical Procedures
D011453:Prostaglandins; D015237:Dinoprost; D015230:Prostaglandin D2